Literature DB >> 19784877

Functional imaging in differentiating bronchial masses: an initial experience with a combination of (18)F-FDG PET-CT scan and (68)Ga DOTA-TOC PET-CT scan.

Arvind Kumar1, Tarun Jindal, Roman Dutta, Rakesh Kumar.   

Abstract

OBJECTIVE: To evaluate the role of combination of (18)F-FDG PET-CT scan and (68)Ga DOTA-TOC PET-CT scan in differentiating bronchial tumors observed in contrast enhanced computed tomography scan of chest. STUDY
DESIGN: Prospective observational study. Place of study: All India Institute of Medical Sciences, New Delhi, India.
METHODS: 7 patients with bronchial mass detected in computed tomography scan of the chest were included in this study. All patients underwent (18)F-FDG PET-CT scan, (68)Ga DOTA-TOC PET-CT scan and fiberoptic bronchoscope guided biopsy followed by definitive surgical excision. The results of functional imaging studies were analyzed and the results are correlated with the final histopathology of the tumor.
RESULTS: Histopathological examination of 7 bronchial masses revealed carcinoid tumors (2 typical, 1 atypical), inflammatory myofibroblastic tumor (1), mucoepidermoid carcinoma (1), hamartoma (1), and synovial cell sarcoma (1). The typical carcinoids had mild (18)F-FDG uptake and high (68)Ga DOTA-TOC uptake. Atypical carcinoid had moderate uptake of (18)F-FDG and high (68)Ga DOTA-TOC uptake. Inflammatory myofibroblastic tumor showed high uptake of (18)F-FDG and no uptake of (68)Ga DOTA-TOC. Mucoepidermoid carcinoma showed mild (18)F-FDG uptake and no (68)Ga DOTA-TOC uptake. Hamartoma showed no uptake on either scans. Synovial cell sarcoma showed moderate (18)F-FDG uptake and mild focal (68)Ga DOTA-TOC uptake.
CONCLUSION: This initial experience with the combined use of (18)F-FDG and (68)Ga DOTA-TOC PET-CT scan reveals different uptake patterns in various bronchial tumors. Bronchoscopic biopsy will continue to be the gold standard; however, the interesting observations made in this study merits further evaluation of the utility of the combination of (18)F-FDG PET-CT scan and (68)Ga DOTA-TOC PET-CT scan in larger number of patients with bronchial masses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19784877     DOI: 10.1007/s12149-009-0302-0

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  6 in total

Review 1.  PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids.

Authors:  Filippo Lococo; Alfredo Cesario; Massimiliano Paci; Angelina Filice; Annibale Versari; Cristian Rapicetta; Tommaso Ricchetti; Giorgio Sgarbi; Marco Alifano; Alberto Cavazza; Giorgio Treglia
Journal:  Tumour Biol       Date:  2014-05-22

2.  Endobronchial Treatment for Bronchial Carcinoid: Patient Selection and Predictors of Outcome.

Authors:  Ellen M B P Reuling; Chris Dickhoff; Peter W Plaisier; Veerle M H Coupé; Albert H A Mazairac; Rutger J Lely; H Jaap Bonjer; Johannes M A Daniels
Journal:  Respiration       Date:  2018-02-12       Impact factor: 3.580

3.  Is 68Ga-DOTATATE the answer in lung carcinoid? : Case report and review of literature.

Authors:  Amit Bhoil; Bhagwant R Mittal; Shankaramurthy Gayana; Raghava Kashyap; Anish Bhattacharya; Navneet Singh
Journal:  Lung India       Date:  2012-10

4.  Inflammatory myofibroblastic tumor of the lung: unusual imaging findings.

Authors:  K Pavithran; P Manoj; G Vidhyadharan; P Shanmughasundaram
Journal:  World J Nucl Med       Date:  2013-09

5.  Value of [68Ga]Ga-somatostatin receptor PET/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and review of the literature.

Authors:  Anne-Leen Deleu; Annouschka Laenen; Herbert Decaluwé; Birgit Weynand; Christophe Dooms; Walter De Wever; Sander Jentjens; Karolien Goffin; Johan Vansteenkiste; Koen Van Laere; Paul De Leyn; Kristiaan Nackaerts; Christophe M Deroose
Journal:  EJNMMI Res       Date:  2022-05-07       Impact factor: 3.434

6.  PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors.

Authors:  Martina Sollini; Paola Anna Erba; Alessandro Fraternali; Massimiliano Casali; Maria Liberata Di Paolo; Armando Froio; Andrea Frasoldati; Annibale Versari
Journal:  ScientificWorldJournal       Date:  2014-02-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.